Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(40 sites)

United States

Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale, Glendale, Arizona

Usc Norris Comprehensive Cancer Center, Los Angeles, California

Rocky Mountain Cancer Centers, Lone Tree, Colorado

Yale University School of Medicine, New Haven, Connecticut

Gnp Research, Cooper City, Florida